Hang Seng Medical ETF (513060) has recently received capital flow, and Internet medical stocks have strengthened

Author:Capital state Time:2022.09.02

In the morning, Hang Seng Medical ETF (513060) shook down, down 0.19%, and the turnover exceeded 200 million yuan.Among the ingredients stocks, Internet medical stocks have strengthened, and Ali Health, Jingdong Health, and Ping An Good Doctors have risen; pioneering pharmaceutical industries rose more than 5%, and Aikang Medical, Hetong Medicine and Xianyin Pharmaceutical rose.

Data show that from January to July 2022, the industrial enterprises above the designated size of the pharmaceutical manufacturing industry achieved operating income of 1608.94 billion yuan, a year-on-year decrease of 1.8%, the growth rate was 8.5%lower than the national industrial revenue; the total profit was 247.36 billion yuan, a year-on-year decrease of 30.7%, The growth rate is less than 18.1%of the overall profit growth of the country.

Zhejiang Business Securities Research Report stated that from January to July 2022, my country's pharmaceutical manufacturing industry recovered slowly, and revenue and profit growth were lower than the overall level of the country.The export of public health prevention and control products from 2020-2021 brought a significant increase in the pharmaceutical manufacturing industry, but the trend of structural adjustment of the pharmaceutical industry has not changed.After the "honeymoon period" of 2018-2021 and the impact of incremental incidents caused by uncontrollable events, the concentration of the pharmaceutical manufacturing industry has just started.

- END -

Xinhua Full Media+丨 Ensure that there is no local scale epidemic before and after the festival -the joint prevention and control mechanism of the State Council responds to epidemic prevention concerns

Xinhua News Agency, Beijing, September 8th: Ensure that no local scale epidemic oc...

Latest notice of the Office of Rizhao Epidemic Prevention and Control Headquarters

Notice on further strengthening the prevention and control of corporate epidemic c...